: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Chronic Heart Failure

Free Subscription

Articles published in Int J Cardiol
Retrieve available abstracts of 465 articles:
HTML format

Single Articles

July 2024

ALBULUSHI A
Assessing the clinical utility of the HFpEF nomogram: A call for broader validation.
Int J Cardiol. 2024;406:132038.
PubMed

NOGIMORI Y, Sato K, Takamizawa K, Ogawa Y, et al
Prediction of adverse cardiovascular events in children using artificial intelligence-based electrocardiogram.
Int J Cardiol. 2024;406:132019.
PubMed Abstract available

June 2024

AIMO A, Arzilli C, Castiglione V, Morfino P, et al
Safety and efficacy of levosimendan in patients with cardiac amyloidosis.
Int J Cardiol. 2024;405:131963.
PubMed Abstract available

CAI Q, Li Q, Zhong S, Chen M, et al
Ultrasound-targeted microbubble destruction rapidly improves left ventricular function in rats with ischemic cardiac dysfunction.
Int J Cardiol. 2024;404:131943.
PubMed Abstract available

May 2024

ZHONG M, Yan X
Inflammation in heart failure with preserved ejection fraction: A bystander or a participant?
Int J Cardiol. 2024;408:132144.
PubMed

COLLUOGLU IT, Celik A, Ata N, Ural D, et al
Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy.
Int J Cardiol. 2024;407:132109.
PubMed Abstract available

ALBULUSHI A, Al Kindi DI, Moawwad N, Kamel AM, et al
Digital health technologies in enhancing patient and caregiver engagement in heart failure management: Opportunities and challenges.
Int J Cardiol. 2024 May 2:132116. doi: 10.1016/j.ijcard.2024.132116.
PubMed Abstract available

SPERLONGANO S, Benfari G, Ilardi F, Lisi M, et al
Role of speckle tracking echocardiography beyond current guidelines in cardiac resynchronization therapy.
Int J Cardiol. 2024;402:131885.
PubMed Abstract available

April 2024

KOZAILY E, Geagea M, Akdogan ER, Atkins J, et al
Accuracy and consistency of online large language model-based artificial intelligence chat platforms in answering patients' questions about heart failure.
Int J Cardiol. 2024 Apr 30:132115. doi: 10.1016/j.ijcard.2024.132115.
PubMed Abstract available

TERAMOTO K, Nochioka K, Sakata Y, Kato ET, et al
Growth differentiation factor-1?5 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum.
Int J Cardiol. 2024 Apr 23:132093. doi: 10.1016/j.ijcard.2024.132093.
PubMed Abstract available

CHEW-HARRIS J, Frampton C, Greer C, Appleby S, et al
Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness.
Int J Cardiol. 2024 Apr 19:132071. doi: 10.1016/j.ijcard.2024.132071.
PubMed Abstract available

PEZZUTO B, Contini M, Berna G, Galotta A, et al
Dynamic trend of lung fluid movement during exercise in heart failure: From lung imaging to alveolar-capillary membrane function.
Int J Cardiol. 2024 Apr 19:132041. doi: 10.1016/j.ijcard.2024.132041.
PubMed Abstract available

HONG Y, Gao Z, Wei H, Wei Y, et al
Bi-directional association of body size and composition with heart failure: A Mendelian randomization study.
Int J Cardiol. 2024 Apr 19:132069. doi: 10.1016/j.ijcard.2024.132069.
PubMed Abstract available

JONG CB, Lu TS, Chen JW
Reply to comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
Int J Cardiol. 2024 Apr 10:132031. doi: 10.1016/j.ijcard.2024.132031.
PubMed

ESPERSEN C, Campbell RT, Claggett BL, Lewis EF, et al
Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure.
Int J Cardiol. 2024 Apr 8:132036. doi: 10.1016/j.ijcard.2024.132036.
PubMed Abstract available

GLINGE C, Rossetti S, Oestergaard LB, Stampe NK, et al
Familial clustering of unexplained heart failure - A Danish nationwide cohort study.
Int J Cardiol. 2024 Apr 5:132028. doi: 10.1016/j.ijcard.2024.132028.
PubMed Abstract available

NAKAO M, Nagai T, Anzai T
Iron supplementation is a residual piece of management in Asian patients with heart failure?
Int J Cardiol. 2024 Apr 4:132014. doi: 10.1016/j.ijcard.2024.132014.
PubMed

DE MICHIELI L, Stoppa G, Sinigiani G, Previato L, et al
Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy.
Int J Cardiol. 2024;400:131804.
PubMed Abstract available

DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
Int J Cardiol. 2024;400:131768.
PubMed Abstract available

GARCIA-MOLL X, Lopez L
Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results.
Int J Cardiol. 2024;400:131706.
PubMed

March 2024

CHENG Y, Zhang Q
Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
PubMed

YAO L, Gong X, Liu Y, Hao K, et al
The miR-195-3p/BDNF axis is a promising therapeutic for heart failure.
Int J Cardiol. 2024 Mar 22:131991. doi: 10.1016/j.ijcard.2024.131991.
PubMed

CARIGI S, Gentile P, Gori M, Tinti D, et al
Clinical characteristics, treatment, trajectories and outcome of patients with dilated cardiomyopathy in a national heart failure registry.
Int J Cardiol. 2024 Mar 19:131986. doi: 10.1016/j.ijcard.2024.131986.
PubMed Abstract available

KARAKITSOS P, Mylonas KS
Raw data were not disclosed in 95% of PubMed-indexed heart failure meta-analyses in 2021: A systematic analysis of transparency.
Int J Cardiol. 2024 Mar 19:131987. doi: 10.1016/j.ijcard.2024.131987.
PubMed Abstract available

HUA L, Zhang R, Chen R, Shao W, et al
A nomogram for predicting the risk of heart failure with preserved ejection fraction.
Int J Cardiol. 2024 Mar 18:131973. doi: 10.1016/j.ijcard.2024.131973.
PubMed Abstract available

LUND-ANDERSEN C, Yafasova A, Hofsten D, Thune JJ, et al
Association between QRS shortening and mortality after cardiac resynchronization therapy: Results from the DANISH study.
Int J Cardiol. 2024;399:131700.
PubMed Abstract available

CHAO-CHEN L
Letter to the Editor: "Changes in walking speed 6 months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure".
Int J Cardiol. 2024 Mar 13:131958. doi: 10.1016/j.ijcard.2024.131958.
PubMed

BACKHAUS SJ, Schulz A, Lange T, Schmidt-Schweda LS, et al
Prognostic and diagnostic implications of impaired rest and exercise-stress left atrial compliance in heart failure with preserved ejection fraction: Insights from the HFpEF stress trial.
Int J Cardiol. 2024 Mar 11:131949. doi: 10.1016/j.ijcard.2024.131949.
PubMed Abstract available

BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
Int J Cardiol. 2024;398:131601.
PubMed Abstract available

February 2024

KIKO T, Aoki T
The relationship between duration of delirium and clinical outcomes in patients with acute heart failure.
Int J Cardiol. 2024 Feb 23:131902. doi: 10.1016/j.ijcard.2024.131902.
PubMed

LUO Z, Gong X, Liu Y, Hao K, et al
Mitochondrial dysfunction due to miR-210/Drd5/ROS axis is a potential mechanism of heart failure.
Int J Cardiol. 2024 Feb 20:131897. doi: 10.1016/j.ijcard.2024.131897.
PubMed

GUAZZI M, Crisci G
Exercise mean PAP to CO relationship: An insightful endpoint for testing therapeutic interventions in heart failure.
Int J Cardiol. 2024 Feb 20:131899. doi: 10.1016/j.ijcard.2024.131899.
PubMed

SIM DKL, Mittal S, Zhang J, Hung CL, et al
Expert recommendations for the management of iron deficiency in patients with heart failure in Asia.
Int J Cardiol. 2024 Feb 19:131890. doi: 10.1016/j.ijcard.2024.131890.
PubMed Abstract available

LERMAN TT, Greenberg N, Fishman B, Goldman A, et al
The real-world safety of sacubitril / valsartan among older adults (>/=75): A pharmacovigilance study from the FDA data.
Int J Cardiol. 2024;397:131613.
PubMed Abstract available

LV L, Chen Q, Lu J, Zhao Q, et al
Potential regulatory role of epigenetic modifications in aging-related heart failure.
Int J Cardiol. 2024 Feb 13:131858. doi: 10.1016/j.ijcard.2024.131858.
PubMed Abstract available

ISMAIL TF
Understanding heart failure and cardiomyopathy in Africa: Insights from cardiovascular magnetic resonance.
Int J Cardiol. 2024 Feb 12:131847. doi: 10.1016/j.ijcard.2024.131847.
PubMed

HAGE C, Lund LH
Inflammation and myeloperoxidase - The next treatment targets in heart failure?
Int J Cardiol. 2024 Feb 5:131834. doi: 10.1016/j.ijcard.2024.131834.
PubMed

LI G, Liu X, Long A, Feng J, et al
An inducible mouse model of heart failure targeted to cardiac Drd5 deficiency detonating mitochondrial oxidative stress.
Int J Cardiol. 2024;396:131560.
PubMed

IANNACCONE M, Barbero U, Franchin L, Montabone A, et al
Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlle
Int J Cardiol. 2024;396:131428.
PubMed Abstract available

January 2024

FERREIRA JP, Claggett BL, Liu J, Sharma A, et al
High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT.
Int J Cardiol. 2024 Jan 31:131818. doi: 10.1016/j.ijcard.2024.131818.
PubMed Abstract available

XU L, Chen Y, Chen S, Wang G, et al
Relationship between resting heart rate and long-term outcomes in stabilized patients with myocardial infarction: A prospective community-based cohort study.
Int J Cardiol. 2024 Jan 24:131811. doi: 10.1016/j.ijcard.2024.131811.
PubMed Abstract available

MIGLIORE F, Schiavone M, Pittorru R, Forleo GB, et al
Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
PubMed Abstract available

YAMAGUCHI N, Hirata Y, Nishio S, Takahashi T, et al
Pulmonary pressure-flow responses to exercise in heart failure treated with angiotensin receptor neprilysin inhibitor.
Int J Cardiol. 2024 Jan 20:131789. doi: 10.1016/j.ijcard.2024.131789.
PubMed Abstract available

MUSUMECI B, Tini G, Biagini E, Merlo M, et al
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
PubMed Abstract available

KANG DW, Kang SH, Lee K, Nam K, et al
Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis.
Int J Cardiol. 2024 Jan 17:131786. doi: 10.1016/j.ijcard.2024.131786.
PubMed Abstract available

CHERBI M, Bouisset F, Bonnefoy E, Lamblin N, et al
Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
Int J Cardiol. 2024;395:131578.
PubMed Abstract available

MUROKE V, Jalanko M, Haukka J, Anttila V, et al
Long-term outcome after surgical correction of sinus venosus defect in a nationwide register-based cohort study.
Int J Cardiol. 2024;395:131433.
PubMed Abstract available

HANADA S, Adachi T, Iwatsu K, Kamisaka K, et al
Changes in walking speed 6?months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure.
Int J Cardiol. 2024 Jan 11:131778. doi: 10.1016/j.ijcard.2024.131778.
PubMed Abstract available

QUATTRONE F, Aimo A, Zuccarino S, Morelli MS, et al
Unmet needs in end-of-life care for heart failure patients.
Int J Cardiol. 2024 Jan 10:131750. doi: 10.1016/j.ijcard.2024.131750.
PubMed Abstract available

AIKAWA Y, Ogata S, Honda S, Nagai T, et al
Prolonged delirium during hospitalization is associated with worse long-term and short-term outcomes in patients with acute heart failure.
Int J Cardiol. 2024 Jan 10:131776. doi: 10.1016/j.ijcard.2024.131776.
PubMed Abstract available

PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
PubMed Abstract available

SRAYA R, Amsalem I, Carasso S, Gilad O, et al
Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
PubMed Abstract available

MIYOSHI T
A novel genetically engineered mouse model for investigating heart failure mechanisms and therapeutic interventions.
Int J Cardiol. 2024 Jan 3:131703. doi: 10.1016/j.ijcard.2023.131703.
PubMed

EGBE AC, Abozied O, Miranda WR, Younis A, et al
Prognostic role of inferior vena collapsibility index in congenital heart disease: A validation study.
Int J Cardiol. 2024;394:131399.
PubMed Abstract available

December 2023

SAEED S, Bleie O
Prognostic validation of first-phase ejection fraction in patients with heart failure: A new piece of evidence.
Int J Cardiol. 2023 Dec 31:131692. doi: 10.1016/j.ijcard.2023.131692.
PubMed

TAN Z, Liu Y, Hong K
The association between serum chloride and mortality in ICU patients with heart failure: The impact of bicarbonate.
Int J Cardiol. 2023 Dec 22:131672. doi: 10.1016/j.ijcard.2023.131672.
PubMed Abstract available

ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
PubMed Abstract available

WONG CN, Gui XY, Rabkin SW
Myeloperoxidase, carnitine, and derivatives of reactive oxidative metabolites in heart failure with preserved versus reduced ejection fraction: A meta-analysis.
Int J Cardiol. 2023 Dec 13:131657. doi: 10.1016/j.ijcard.2023.131657.
PubMed Abstract available

OZLEK B
Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
PubMed

HU H, Yang J
Heart failure complicated by atrial fibrillation: How to make better choices for anticoagulation?
Int J Cardiol. 2023 Dec 6:131644. doi: 10.1016/j.ijcard.2023.131644.
PubMed

ELIA E, Bruno F, Crimi G, Wanha W, et al
Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.
Int J Cardiol. 2023 Dec 5:131622. doi: 10.1016/j.ijcard.2023.131622.
PubMed Abstract available

GAO Y, Liu M, Ju Z, Wang H, et al
Entropy as a novel predictor of cardiovascular events in patients with left ventricular noncompaction.
Int J Cardiol. 2023;392:131279.
PubMed Abstract available

November 2023

JIN C, Chen G, Zhao C, Wu Y, et al
First-phase ejection fraction to predict adverse outcomes in patients with heart failure.
Int J Cardiol. 2023 Nov 30:131612. doi: 10.1016/j.ijcard.2023.131612.
PubMed Abstract available

CHOI HM, Hwang IC, Choi HJ, Yoon YE, et al
Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients.
Int J Cardiol. 2023 Nov 27:131611. doi: 10.1016/j.ijcard.2023.131611.
PubMed Abstract available

MORONI F, Corna G, Del Buono MG, Golino M, et al
Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction.
Int J Cardiol. 2023 Nov 26:131610. doi: 10.1016/j.ijcard.2023.131610.
PubMed Abstract available

TAYAL B, Rorth R, Kristensen SL, Wissenberg M, et al
Comparative outcomes in patients with preexisting heart failure to those without heart failure after out-of-hospital cardiac arrest: A nationwide registry study.
Int J Cardiol. 2023 Nov 18:131595. doi: 10.1016/j.ijcard.2023.131595.
PubMed Abstract available

ALEXANDRINO FB, Faaborg-Andersen CC, da Silva-de Abreu A
Anticoagulation in patients with atrial fibrillation and heart failure: More than meets the eye?
Int J Cardiol. 2023 Nov 16:131591. doi: 10.1016/j.ijcard.2023.131591.
PubMed

LAU ATC, DiDomenico RJ, Kim K
Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with Heart failure with preserved ejection fraction (HFpEF) in United States.
Int J Cardiol. 2023 Nov 16:131598. doi: 10.1016/j.ijcard.2023.131598.
PubMed Abstract available

ROSSI VA, Laptseva N, Nebunu D, Haider T, et al
Impaired retinal micro-vascular function in patients with atrial fibrillation.
Int J Cardiol. 2023 Nov 16:131592. doi: 10.1016/j.ijcard.2023.131592.
PubMed Abstract available

D'AMARIO D, Laborante R, Bianchini E, Galli M, et al
Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials.
Int J Cardiol. 2023;391:131219.
PubMed Abstract available

CHAVALI S, Barua S, Adji A, Robson D, et al
Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices.
Int J Cardiol. 2023;391:131259.
PubMed Abstract available

LI ZH, Zhong WF, Qiu CS, Yang P, et al
Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
Int J Cardiol. 2023 Nov 5:131567. doi: 10.1016/j.ijcard.2023.131567.
PubMed Abstract available

DORES H, Toste A, Cardim N
Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
Int J Cardiol. 2023;390:131260.
PubMed Abstract available

October 2023

MASE M, Rossi M, Setti M, Barbati G, et al
Applicability and performance of heart failure prognostic scores in dilated cardiomyopathy: The real-world experience of an Italian referral center for cardiomyopathies.
Int J Cardiol. 2023 Oct 29:131562. doi: 10.1016/j.ijcard.2023.131562.
PubMed Abstract available

KOSEOGLU FD, Ozlek B
Hemoglobin to red cell distribution width ratio in patients with heart failure with preserved ejection fraction.
Int J Cardiol. 2023 Oct 27:131556. doi: 10.1016/j.ijcard.2023.131556.
PubMed

SERAFIN A, Jasic-Szpak E, Marwick TH, Przewlocka-Kosmala M, et al
Contribution of reduced skeletal muscle perfusion reserve to exercise intolerance in heart failure with preserved ejection fraction.
Int J Cardiol. 2023 Oct 21:131553. doi: 10.1016/j.ijcard.2023.131553.
PubMed Abstract available

SERI A, Rabadi A, Baral N, Andi K, et al
Prevalence of respiratory failure and use of mechanical ventilation in heart failure patients undergoing left atrial appendage occlusion device implantation.
Int J Cardiol. 2023 Oct 21:131552. doi: 10.1016/j.ijcard.2023.131552.
PubMed Abstract available

ZITO A, Restivo A, D'Amario D
Reply to "Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis".
Int J Cardiol. 2023 Oct 20:131545. doi: 10.1016/j.ijcard.2023.131545.
PubMed

ANSARI RAMANDI MM, Yarmohammadi H, Gareb B, Voors AA, et al
Long-term outcome of patients with transposition of the great arteries and a systemic right ventricle: A systematic review and meta-analysis.
Int J Cardiol. 2023;389:131159.
PubMed Abstract available

JAIN SS, Yu J, Arnott C, Neal B, et al
Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial.
Int J Cardiol. 2023 Oct 14:131444. doi: 10.1016/j.ijcard.2023.131444.
PubMed Abstract available

IMANISHI J, Iwasaki M, Ujiro S, Nakano T, et al
Accuracy of lung ultrasound examinations of residual congestion performed by novice residents in patients with acute heart failure.
Int J Cardiol. 2023 Oct 14:131446. doi: 10.1016/j.ijcard.2023.131446.
PubMed Abstract available

LEONARDI D, Bursi F, Fanti D, Dotto A, et al
Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
PubMed Abstract available

MOCKEL M, Pudasaini S, Baberg HT, Levenson B, et al
Oral anticoagulation in heart failure complicated by atrial fibrillation: A nationwide routine data study.
Int J Cardiol. 2023 Oct 10:131434. doi: 10.1016/j.ijcard.2023.131434.
PubMed Abstract available

ROONGSANGMANOON W, Wongsoasup A, Chichareon P, Suwannasom P, et al
Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
Int J Cardiol. 2023;388:131167.
PubMed Abstract available

September 2023

ZHENG H, Yin Z, Luo X, Zhou Y, et al
Associations between systemic immunity-inflammation index and heart failure: Evidence from the NHANES 1999-2018.
Int J Cardiol. 2023 Sep 26:131400. doi: 10.1016/j.ijcard.2023.131400.
PubMed Abstract available

FONDERICO C, Pergola V, Faccenda D, Salucci A, et al
Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients.
Int J Cardiol. 2023 Sep 23:131391. doi: 10.1016/j.ijcard.2023.131391.
PubMed Abstract available

BAUMHOVE L, Bomer N, Tromp J, van Essen BJ, et al
Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D.
Int J Cardiol. 2023 Sep 21:131384. doi: 10.1016/j.ijcard.2023.131384.
PubMed Abstract available

CHEN H, Zhen Z, Dong Y, Liu C, et al
Hemoglobin to red cell distribution width ratio: A predictor of clinical outcome and diuretic response in patients with acute heart failure.
Int J Cardiol. 2023 Sep 20:131368. doi: 10.1016/j.ijcard.2023.131368.
PubMed Abstract available

LI T, Li Z, Guo S, Jiang S, et al
The value of using left ventricular pressure-strain loops to evaluate myocardial work in predicting heart failure with improved ejection fraction.
Int J Cardiol. 2023 Sep 19:131366. doi: 10.1016/j.ijcard.2023.131366.
PubMed Abstract available

ANDI K, Abozied O, Miranda WR, Anderson JH, et al
Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease.
Int J Cardiol. 2023;387:131152.
PubMed Abstract available

TSABEDZE N, Mpanya D, Bailly C, Nel S, et al
Clinical characteristics and one-year all-cause mortality outcomes in Africans with dilated cardiomyopathy.
Int J Cardiol. 2023;387:131142.
PubMed Abstract available

LEE YH, Kim SM, Kim EK, Park SJ, et al
Pattern of pericardial calcification determines mid-term postoperative outcomes after pericardiectomy in chronic constrictive pericarditis.
Int J Cardiol. 2023;387:131133.
PubMed Abstract available

ZHANG TY, An DA, Zhou H, Ni Z, et al
Fractal analysis: Left ventricular trabecular complexity cardiac MRI adds independent risks for heart failure with preserved ejection fraction in participants with end-stage renal disease.
Int J Cardiol. 2023 Sep 9:131334. doi: 10.1016/j.ijcard.2023.131334.
PubMed Abstract available

LEE K, Jung JH, Kwon W, Ohn C, et al
The prognostic value of cardiopulmonary exercise testing and HFA-PEFF in patients with unexplained dyspnea and preserved left ventricular ejection fraction.
Int J Cardiol. 2023;386:74-82.
PubMed Abstract available

August 2023

KHAZAEI S, Jenabi E
Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis.
Int J Cardiol. 2023 Aug 22:131281. doi: 10.1016/j.ijcard.2023.131281.
PubMed

PUST F, Deis T, Larsson J, Hansen BL, et al
Importance of heart failure duration for development of pulmonary hypertension in advanced heart failure.
Int J Cardiol. 2023 Aug 19:131232. doi: 10.1016/j.ijcard.2023.131232.
PubMed Abstract available

CHO Y, Ueda T, Kotani S, Okada K, et al
AATS 2023: Left ventricular restoration with scar exclusion in the surgical treatment for ischemic heart failure.
Int J Cardiol. 2023 Aug 18:131277. doi: 10.1016/j.ijcard.2023.131277.
PubMed Abstract available

DOGAR ME, Azeem B, Asim R
Comment on SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.
Int J Cardiol. 2023 Aug 9:131255. doi: 10.1016/j.ijcard.2023.131255.
PubMed

LO JJ, Tromp J, Ouwerkwerk W, Ong MEH, et al
Examining predictors for 6-month mortality and healthcare utilization for patients admitted for heart failure in the acute care setting.
Int J Cardiol. 2023 Aug 1:131237. doi: 10.1016/j.ijcard.2023.131237.
PubMed Abstract available

July 2023

SANCHIS L, Farrero M
Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
PubMed

DE CLERCQ L, Er A, Handoko ML, van Weert HCPM, et al
Characteristics of heart failure in the Amsterdam metropolitan area (AMSTERDAM-HF): Data from a dynamic general practice cohort (2011-2021).
Int J Cardiol. 2023 Jul 25:131217. doi: 10.1016/j.ijcard.2023.131217.
PubMed Abstract available

TAVERAS HIRALDO A, Canahuate Rodriguez G
Predicting heart failure rollback.
Int J Cardiol. 2023 Jul 20:131197. doi: 10.1016/j.ijcard.2023.131197.
PubMed

JONG CB, Lu TS, Chen TY, Chen CK, et al
Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome.
Int J Cardiol. 2023 Jul 18:131195. doi: 10.1016/j.ijcard.2023.131195.
PubMed Abstract available

PAVLOV M, Vidak M
Safety of benzodiazepines in patients with acute heart failure: Questions to be answered.
Int J Cardiol. 2023 Jul 14:131191. doi: 10.1016/j.ijcard.2023.131191.
PubMed

ICHIHARA YK, Shiraishi Y, Kohsaka S, Nakano S, et al
Association of pre-hospital precipitating factors with short- and long-term outcomes of acute heart failure patients: A report from the WET-HF2 registry.
Int J Cardiol. 2023 Jul 10:131161. doi: 10.1016/j.ijcard.2023.131161.
PubMed Abstract available

ZITO A, Restivo A, Ciliberti G, Laborante R, et al
Heart failure management guided by remote multiparameter monitoring: A meta-analysis.
Int J Cardiol. 2023 Jul 8:131163. doi: 10.1016/j.ijcard.2023.131163.
PubMed Abstract available

SUN Y, Wang C, Ren J
CRT upgrading might be a potential therapy in pacemaker-induced cardiomyopathy.
Int J Cardiol. 2023;382:62.
PubMed

WANG RJ, Xu C, Tang HF
A cardiovascular polypharmacy perspective on octogenarians with HFpEF.
Int J Cardiol. 2023;382:60-61.
PubMed

June 2023

CASTIGLIONE V, Gentile F, Vergaro G
Cachexia, sarcopenia and heart failure: A last mile to be walked.
Int J Cardiol. 2023 Jun 24:131131. doi: 10.1016/j.ijcard.2023.131131.
PubMed

MORITA K, Miyamoto Y, Mizuno A, Shirane S, et al
Impact of a financial incentive scheme for team-based palliative care in patients with heart failure in Japan: A nationwide database study.
Int J Cardiol. 2023 Jun 24:131145. doi: 10.1016/j.ijcard.2023.131145.
PubMed Abstract available

MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
The long-term clinical course of moderate tricuspid regurgitation.
Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
PubMed Abstract available

MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
PubMed Abstract available

GALATI G, Germanova O, Pedretti RFE, Ambrosio G, et al
Hypotension and optimization of heart failure therapy after a recent hospitalization for heart failure: When the going gets tough, the tough get going.
Int J Cardiol. 2023 Jun 13:131118. doi: 10.1016/j.ijcard.2023.131118.
PubMed

CAMILLI M, Iannaccone G, Russo M, Meucci MC, et al
Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study.
Int J Cardiol. 2023 Jun 6:S0167-5273(23)00835.
PubMed Abstract available

May 2023

ZHANG X, Lv X, Wang N, Yu S, et al
WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.
Int J Cardiol. 2023 May 29:S0167-5273(23)00738.
PubMed Abstract available

MUTOLI M, Martelli F, Spinetti G
TfR1 gene expression as a potential biomarker for iron deficiency in heart failure.
Int J Cardiol. 2023 May 23:S0167-5273(23)00722.
PubMed

WU L, Wu M, Zhang X, Chen S, et al
Increased arterial stiffness elevates the risk of heart failure in diabetic patients.
Int J Cardiol. 2023 May 23:S0167-5273(23)00732.
PubMed Abstract available

ANGELICO-GONCALVES A, Leite AR, Neves JS, Saraiva F, et al
Changes in health-related quality of life and treatment effects in chronic heart failure: A meta-analysis.
Int J Cardiol. 2023 May 19:S0167-5273(23)00726.
PubMed Abstract available

MEIJS C, Brugts JJ, Lund LH, Linssen GCM, et al
Identifying distinct clinical clusters in heart failure with mildly reduced ejection fraction.
Int J Cardiol. 2023 May 16:S0167-5273(23)00718.
PubMed Abstract available

CABRERA C, Frisk C, Lofstrom U, Lynga P, et al
Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle.
Int J Cardiol. 2023;379:82-88.
PubMed Abstract available

KUCHTARUK AA, Sparrow RT, Azzalini L, Garcia S, et al
Unplanned readmissions after Impella mechanical circulatory support.
Int J Cardiol. 2023;379:48-59.
PubMed Abstract available

ALHAKAK AS, Olsen FJ, Skaarup KG, Lassen MCH, et al
Changes in cardiac time intervals over a decade and the risk of incident heart failure: The Copenhagen City heart study.
Int J Cardiol. 2023 May 11:S0167-5273(23)00709.
PubMed Abstract available

MELENDO-VIU M, Dobarro D, Lopez AM, Dominguez LM, et al
Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?
Int J Cardiol. 2023 May 9:S0167-5273(23)00658.
PubMed Abstract available

MAGRI D, Palermo P, Salvioni E, Mapelli M, et al
Influence of exertional oscillatory breathing and its temporal behavior in patients with heart failure and reduced ejection fraction.
Int J Cardiol. 2023 May 8:S0167-5273(23)00659.
PubMed Abstract available

FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
PubMed Abstract available

KOH SJQ, Yap J, Jiang Y, Sng GGR, et al
Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study.
Int J Cardiol. 2023;378:105-110.
PubMed Abstract available

April 2023

ASAUMI Y
Peripheral vein pressure as a less-invasive marker at the vulnerable phase after hospitalization of heart failure.
Int J Cardiol. 2023 Apr 28:S0167-5273(23)00593.
PubMed

BOTTIROLI M, Calini A, Morici N, Tavazzi G, et al
Acute kidney injury in patients with acute decompensated heart failure-cardiogenic shock: Prevalence, risk factors and outcome.
Int J Cardiol. 2023 Apr 28:S0167-5273(23)00612.
PubMed Abstract available

ZEITOUNI M, Morlon Q, Silvain J, Procopi N, et al
Implication of the new definition of pulmonary hypertension in patients evaluated for heart transplantation.
Int J Cardiol. 2023 Apr 27:S0167-5273(23)00602.
PubMed Abstract available

SINGAM NSV, Tabi M, Wiley B, Anavekar N, et al
Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
Int J Cardiol. 2023 Apr 26:S0167-5273(23)00595.
PubMed Abstract available

NISHINO M, Egami Y, Yamada T, Yasumura Y, et al
Reply to "Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction".
Int J Cardiol. 2023 Apr 17:S0167-5273(23)00536.
PubMed

FERREIRA JP, Cleland JG, Girerd N, Rossignol P, et al
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
Int J Cardiol. 2023;377:86-88.
PubMed Abstract available

CHRISTOPH M, Marius S, Karl S, Friedrich K, et al
Efficacy of CRT upgrade in pacemaker-induced cardiomyopathy in an outpatient clinic - Results of a prospective registry.
Int J Cardiol. 2023;377:60-65.
PubMed Abstract available

YANG Q, Wu H, Liu D, Li Y, et al
Discussion of a study on the role of EMS in prognosis of elderly patients with AHF.
Int J Cardiol. 2023;377:91.
PubMed

SALAMANCA-BAUTISTA P, Romero-Correa M, Formiga F, Antequera-Martin-Portugues I, et al
Safety of benzodiazepines in patients with acute heart failure: A propensity score-matching study.
Int J Cardiol. 2023 Apr 14:S0167-5273(23)00529.
PubMed Abstract available

EDER M, Griffin M, Moreno-Villagomez J, Bellumkonda L, et al
The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial.
Int J Cardiol. 2023 Apr 4:S0167-5273(23)00517.
PubMed Abstract available

March 2023

LUO Q, Zhuang B, Li G, Jiang Y, et al
Consistency evaluation of exercise target heart rate determined by resting heart rate and anaerobic threshold in chronic heart failure patients.
Int J Cardiol. 2023 Mar 29:S0167-5273(23)00467.
PubMed Abstract available

HORTEGAL RA, Valeri R, Grizante M, Cancellier R, et al
Afterload increase challenge unmasks systolic abnormalities in heart failure with preserved ejection fraction.
Int J Cardiol. 2023 Mar 21:S0167-5273(23)00453.
PubMed Abstract available

FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
Prevalence and prognostic impact of the coexistence of cachexia and sarcopenia in older patients with heart failure.
Int J Cardiol. 2023 Mar 17:S0167-5273(23)00447.
PubMed Abstract available

TAKIMURA H, Taniguchi R, Tsuzuki I, Tajima E, et al
Impact of the time-to-target rate of urine volume concept on the outcome of acute decompensated heart failure.
Int J Cardiol. 2023 Mar 17:S0167-5273(23)00445.
PubMed Abstract available

KUMAR HU, Nearing BD, Mittal S, Premchand RK, et al
Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study results.
Int J Cardiol. 2023 Mar 17:S0167-5273(23)00440.
PubMed Abstract available

ZHANG HD, Yan Y, He YY, Liu QQ, et al
Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease.
Int J Cardiol. 2023;375:29-35.
PubMed Abstract available

LI X, Shen Y, Xu X, Guo G, et al
Genomic and RNA-Seq profiling of patients with HFrEF unraveled OAS1 mutation and aggressive expression.
Int J Cardiol. 2023;375:44-54.
PubMed Abstract available

FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
Prognostic implications of six-minute walking distance in patients with heart failure with preserved ejection fraction.
Int J Cardiol. 2023 Mar 11:S0167-5273(23)00396.
PubMed Abstract available

BURGER PM, Koudstaal S, Dorresteijn JAN, Savarese G, et al
Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
Int J Cardiol. 2023 Mar 11:S0167-5273(23)00395.
PubMed Abstract available

HEEGAARD B, Deis T, Rossing K, Ersboll M, et al
Diabetes mellitus and hemodynamics in advanced heart failure.
Int J Cardiol. 2023 Mar 10:S0167-5273(23)00341.
PubMed Abstract available

KAWAJI T, Shiomi H, Bao B, Hojo S, et al
Intracardiac energy inefficiency during atrial fibrillation rhythm with heart failure: Assessment by echo-vector flow mapping.
Int J Cardiol. 2023 Mar 10:S0167-5273(23)00392.
PubMed Abstract available

DURAN A, Ventura HO
The value of frequent objective risk assessments in heart failure management.
Int J Cardiol. 2023 Mar 6:S0167-5273(23)00333.
PubMed

MOHEBI R, Liu Y, Murphy SP, Gaggin HK, et al
Clinical profiling of end-stage heart failure with preserved ejection fraction: The National Readmission Database.
Int J Cardiol. 2023 Mar 2:S0167-5273(23)00269.
PubMed Abstract available

ZAMPIERI M, Salvi S, Fumagalli C, Argiro A, et al
Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
Int J Cardiol. 2023;374:65-72.
PubMed Abstract available

LIU Y, Li Y, Zhang J, Zhao Y, et al
Pregnancy outcomes of women with Eisenmenger syndrome: A single-center study.
Int J Cardiol. 2023;374:35-41.
PubMed Abstract available

February 2023

DIEZ MPL, Alquezar-Arbe A, Jacob J, Llorens P, et al
Hospital development of heart failure follow-up units and short-term prognosis after acute decompensation in Spain.
Int J Cardiol. 2023 Feb 17:S0167-5273(23)00247.
PubMed Abstract available

SEFEROVIC PM, Polovina M, Seferovic J, Rosano G, et al
Corrigendum to "Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes" [International Journal of Cardiology 2023 Jan 15;371:293-294 10.1016/j.ijcard.2022.09.019.
Int J Cardiol. 2023 Feb 16:S0167-5273(23)00232.
PubMed

XING C, Wang X, Pan X, Yu J, et al
Outcomes of atrial septostomy and effect on long-term survival in patients with idiopathic pulmonary arterial hypertension: A single-center cohort.
Int J Cardiol. 2023;373:118-123.
PubMed Abstract available

SHIROTANI S, Jujo K, Takada T, Abe T, et al
Renin-angiotensin system inhibitor exerts prognostic effects in HFpEF patients with low baseline chloride level.
Int J Cardiol. 2023;373:83-89.
PubMed Abstract available

NISHINO M, Egami Y, Kawanami S, Sugae H, et al
Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
PubMed Abstract available

KERSTENS TP, Weerts J, van Dijk APJ, Weijers G, et al
Left ventricular strain-volume loops and diastolic dysfunction in suspected heart failure with preserved ejection fraction.
Int J Cardiol. 2023 Feb 14:S0167-5273(23)00167.
PubMed Abstract available

YANAGISAWA S, Inden Y, Murohara T
Catheter ablation for atrial fibrillation in heart failure: Getting closer to the full picture in the whole population.
Int J Cardiol. 2023 Feb 13:S0167-5273(23)00226.
PubMed

GOES-SANTOS BR, Rondon E, Fonseca GWP, Sales ARK, et al
Physical capacity increase in patients with heart failure is associated with improvement in muscle sympathetic nerve activity.
Int J Cardiol. 2023 Feb 13:S0167-5273(23)00234.
PubMed Abstract available

CAMPBELL-QUINTERO S, Echeverria LE, Gomez-Mesa JE, Rivera-Toquica A, et al
Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
Int J Cardiol. 2023 Feb 13:S0167-5273(23)00236.
PubMed Abstract available

KOSTANJSEK L, Ardissino M, Moussa O, Rayes B, et al
Effect of bariatric surgery on the incidence of heart failure: A propensity score matched nationwide cohort study.
Int J Cardiol. 2023 Feb 2:S0167-5273(23)00169.
PubMed Abstract available

January 2023

NGUYEN BN, Mital S, Bugden S, Nguyen HV, et al
Cost-effectiveness of dapagliflozin and empagliflozin for treatment of heart failure with reduced ejection fraction.
Int J Cardiol. 2023 Jan 31:S0167-5273(23)00120.
PubMed Abstract available

PEZZUTO B, Piepoli M, Galotta A, Sciomer S, et al
The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database.
Int J Cardiol. 2023 Jan 27:S0167-5273(23)00110.
PubMed Abstract available

WERNHART S, Papathanasiou M, Rassaf T, Luedike P, et al
Heart failure classification based on resting ejection fraction does not display a unique exercise response pattern.
Int J Cardiol. 2023 Jan 27:S0167-5273(23)00113.
PubMed Abstract available

CASULA M, Pignalosa L, Quilico F, Scajola LV, et al
A comprehensive meta-analysis comparing radiofrequency ablation versus pharmacological therapy for the treatment of atrial fibrillation in patients with heart failure.
Int J Cardiol. 2023 Jan 26:S0167-5273(23)00111.
PubMed Abstract available

CANEPA M, Leporatti L, Persico L, Ameri P, et al
Corrigendum to "Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy" [Int J Cardiol. 2022 Sep 15;363:111-118].
Int J Cardiol. 2023 Jan 20:S0167-5273(23)00057.
PubMed

KONG G, Chin YH, Chong B, Goh RSJ, et al
Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients.
Int J Cardiol. 2023;371:432-440.
PubMed Abstract available

KIRSCH M, Feriel M, Aurelia LT, Oksana K, et al
Impact of training on combined cardiopulmonary exercise test with stress echocardiography parameters in HFrEF patients.
Int J Cardiol. 2023;371:252-258.
PubMed Abstract available

TOTO F, Salvioni E, Magri D, Sciomer S, et al
Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base.
Int J Cardiol. 2023;371:273-277.
PubMed Abstract available

LIANG J, Zhang Z
Predictors of in-hospital heart failure in patients with acute anterior wall ST-segment elevation myocardial infarction.
Int J Cardiol. 2023 Jan 10:S0167-5273(23)00043.
PubMed Abstract available

MIYAMOTO R, Nagao K, Matsuto K, Hata R, et al
Relationship between atrial fibrillation and a liver fibrogenesis marker in patients with acute heart failure.
Int J Cardiol. 2023 Jan 10:S0167-5273(23)00001.
PubMed Abstract available

IWAHASHI N
Right ventricular strain and mechanical dispersion for heart failure with preserved ejection fraction.
Int J Cardiol. 2023 Jan 5:S0167-5273(22)01977.
PubMed

MATSUTO K, Maruichi-Kawakami S, Aida K, Imamoto K, et al
Prognostic implications of post-discharge hemodynamic congestion assessed by peripheral venous pressure among patients discharged from acute heart failure.
Int J Cardiol. 2023 Jan 4:S0167-5273(22)01982.
PubMed Abstract available

GALASSI A, Cara A, Magagnoli L, Faccioli FM, et al
Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns.
Int J Cardiol. 2023;370:321-322.
PubMed

TROMBARA F, Alimento ML
Should we be afraid of moderate hyperkalemia in HFrEF outpatients?
Int J Cardiol. 2023;370:323-324.
PubMed

ZANNONI J, Guazzi M, Milani V, Bandera F, et al
Prognostic value of cardiopulmonary exercise testing in a European cohort with cardiovascular risk factors absent of a cardiovascular disease diagnosis.
Int J Cardiol. 2023;370:402-404.
PubMed Abstract available

LUND LH, Zeymer U, Clark AL, Barrios V, et al
Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry.
Int J Cardiol. 2023;370:279-286.
PubMed Abstract available

December 2022

KOBAYASHI M, Ferreira JP, Matsue Y, Chikamori T, et al
Effect of eplerenone on clinical stability of Japanese patients with acute heart failure.
Int J Cardiol. 2022 Dec 28:S0167-5273(22)01938.
PubMed Abstract available

KURASHIMA S, Kitai T, Matsue Y, Nogi K, et al
Trajectory of serum chloride levels during decongestive therapy in acute heart failure.
Int J Cardiol. 2022 Dec 27:S0167-5273(22)01933.
PubMed Abstract available

AMPARO TAVERAS H
The dilemma of thromboembolism prophylaxis in patient with acute heart failure.
Int J Cardiol. 2022 Dec 16:S0167-5273(22)01913.
PubMed

JUG B
Heart failure with reduced ejection fraction and low blood pressure: Overcoming another barrier to guideline-directed medical therapy?
Int J Cardiol. 2022 Dec 8:S0167-5273(22)01882.
PubMed

KAUR G, Jones M, Howes L, Hattingh HL, et al
Systematic review and meta-analysis of the association between all-cause mortality and statin therapy in patients with preserved ejection fraction heart failure (HFpEF).
Int J Cardiol. 2022 Dec 7:S0167-5273(22)01871.
PubMed Abstract available

WEWER ALBRECHTSEN NJ, Bojsen-Moller KN
Letter to the Editor regarding to 'Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control'.
Int J Cardiol. 2022;368:55.
PubMed

November 2022

SEPHIEN A, Ghobrial M, Reljic T, Prida X, et al
Efficacy of SGLT2 inhibitors in patients with heart failure: An overview of systematic reviews.
Int J Cardiol. 2022 Nov 28:S0167-5273(22)01739.
PubMed Abstract available

VAN BERGEIJK KH, Wykrzykowska JJ, Sartori S, Snyder C, et al
Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.
Int J Cardiol. 2022 Nov 28:S0167-5273(22)01743.
PubMed Abstract available

KANG Y, Hwang HY
Carbohydrate antigen 125; A biomarker not only for medical patients but also for surgical patients with heart failure.
Int J Cardiol. 2022 Nov 26:S0167-5273(22)01733.
PubMed

DU Y, Yuan N, Yan J, Han G, et al
Identification of echocardiographic subgroups in patients with coronary heart disease combined with heart failure based on latent variable stratification.
Int J Cardiol. 2022 Nov 25:S0167-5273(22)01725.
PubMed Abstract available

MAHTANI K, Patel B, Wang B, Barron A, et al
Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control.
Int J Cardiol. 2022;367:81-89.
PubMed Abstract available

HAMATANI Y, Kato T, Morimoto T, Iguchi M, et al
Association of intravenous heparin administration with in-hospital clinical outcomes among hospitalized patients with acute heart failure.
Int J Cardiol. 2022 Nov 11. pii: S0167-5273(22)01705.
PubMed Abstract available

CAI J, Zhang L, Chen C, Ge J, et al
Association between serum klotho concentration and heart failure in adults, a cross-sectional study from NHANES 2007-2016.
Int J Cardiol. 2022 Nov 6. pii: S0167-5273(22)01697.
PubMed Abstract available

PASQUALIN G, Chessa M
HFpEF, HFmEF, HFrEF in adults with congenital heart disease: Time to face it.
Int J Cardiol. 2022;366:19.
PubMed

GOMEZ-HOSPITAL JA, Ferreiro JL
Percutaneous circulatory support in high-risk PCI: Pulsatile or continuous flow devices?
Int J Cardiol. 2022;366:80-81.
PubMed

October 2022

SHANAH L, Mir T, Uddin MM, Hussain T, et al
Clinical outcomes and 30-day readmissions for heart failure with reduced ejection fraction with cardiorenal syndrome: A National Cohort Study.
Int J Cardiol. 2022 Oct 31. pii: S0167-5273(22)01672.
PubMed Abstract available

DE FILIPPO O, D'Ascenzo F, Wojciech W, Leonardi S, et al
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.
Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01658.
PubMed Abstract available

FAABORG-ANDERSEN CC, daSilva-deAbreu A, Ventura HO
Optimized dosing of guideline-directed medical therapies is essential in heart failure with reduced ejection fraction.
Int J Cardiol. 2022 Oct 20. pii: S0167-5273(22)01648.
PubMed

BEREZIN AE
Heart failure with recovered ejection fraction: The role of HbA1c level in hospitalized heart failure patients with type 2 diabetes.
Int J Cardiol. 2022 Oct 19. pii: S0167-5273(22)01531.
PubMed

KANEKO T, Kagiyama N, Nakamura Y, Dotare T, et al
External validation of the ACUTE HF score for risk stratification in acute heart failure.
Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01641.
PubMed Abstract available

KISHIHARA M, Takada T, Jujo K, Shirotani S, et al
Prognostic impact of guideline-directed medical therapy in patients with heart failure on regular hemodialysis.
Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01642.
PubMed Abstract available

IZUMI K, Kohno T, Goda A, Takeuchi S, et al
Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01640.
PubMed Abstract available

TAKEUCHI S, Kohno T, Goda A, Shiraishi Y, et al
Malnutrition in real-world patients hospitalized for heart failure with preserved ejection fraction and its potential impact on generalizability of EMPEROR-Preserved trial.
Int J Cardiol. 2022 Oct 15. pii: S0167-5273(22)01533.
PubMed Abstract available

PROFF J, Merkely B, Papp R, Lenz C, et al
Closed loop stimulation in patients with chronic heart failure and severe chronotropic incompetence: Responders versus non-responders.
Int J Cardiol. 2022 Oct 12. pii: S0167-5273(22)01530.
PubMed Abstract available

SIMON W, Maria P, Mahabadi AA, Tienush R, et al
Betablockers reduce oxygen pulse increase and performance in heart failure patients with preserved ejection fraction.
Int J Cardiol. 2022 Oct 8. pii: S0167-5273(22)01478.
PubMed Abstract available

CHEN A, Geng Z, Zhang Y
Efficacy and safety of early cardiac rehabilitation for patients with heart failure.
Int J Cardiol. 2022 Oct 5. pii: S0167-5273(22)01471.
PubMed

CASTRO-PORTILLO E, Lopez-Izquierdo R, Sanz-Garcia A, Ortega GJ, et al
Role of prehospital point-of-care N-terminal pro-brain natriuretic peptide in acute life-threatening cardiovascular disease.
Int J Cardiol. 2022;364:126-132.
PubMed Abstract available

September 2022

LI L, Tu B, Liu S, Zhang Z, et al
Sex differences in ventricular arrhythmias epidemiology, risk factors, and mortality in congestive heart failure.
Int J Cardiol. 2022 Sep 28. pii: S0167-5273(22)01415.
PubMed Abstract available

PICCINNI C, Dondi L, Calabria S, Ronconi G, et al
How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases.
Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01403.
PubMed Abstract available

LI X, Zuo C, Chen C, Tian D, et al
Effectiveness and safety evaluation of sacubitril/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: A prospective cohort study.
Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01400.
PubMed Abstract available

AMIOKA M, Sanada R, Matsumura H, Kinoshita H, et al
Impact of SGLT2 inhibitors on old age patients with heart failure and chronic kidney disease.
Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01409.
PubMed Abstract available

JARJOUR M, Leclerc J, Bouabdallaoui N, Ahnadi C, et al
Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes.
Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01408.
PubMed Abstract available

ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
Int J Cardiol. 2022;363:1-5.
PubMed Abstract available

STAMATELOPOULOS K, Delialis D, Georgiopoulos G, Tselegkidi MI, et al
Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.
Int J Cardiol. 2022;363:102-110.
PubMed Abstract available

YANG CD, Aihemaiti M, Quan JW, Chen JW, et al
HbA1c level is associated with the development of heart failure with recovered ejection fraction in hospitalized heart failure patients with type 2 diabetes.
Int J Cardiol. 2022 Sep 15. pii: S0167-5273(22)01339.
PubMed Abstract available

SEFEROVIC PM, Polovina M, Seferovic J, Rosano G, et al
Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes.
Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01328.
PubMed

HIGUCHI S, Orban M, Adamo M, Giannini C, et al
Sex-specific impact of anthropometric parameters on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation.
Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01337.
PubMed Abstract available

MAHABADI AA, Anapliotis V, Dykun I, Rassaf T, et al
Response to: Epicardial adipose tissue in heart failure: A promising therapeutic target.
Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01326.
PubMed

MIAO C, Tang ZW, Nie F
Epicardial adipose tissue in heart failure: A promising therapeutic target.
Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01327.
PubMed

PASTORE MC, Mandoli GE, Stefanini A, Ghionzoli N, et al
Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value.
Int J Cardiol. 2022 Sep 3. pii: S0167-5273(22)01266.
PubMed Abstract available

BURRI H
Electrical remodeling and super-response with biventricular and conduction system pacing: Can cardiac resynchronization therapy be curative?
Int J Cardiol. 2022;362:83-84.
PubMed

KHAZAEI S, Khazaei M
Comment on: Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
Int J Cardiol. 2022;362:152.
PubMed

August 2022

GIL FR, Brida M
Response to Letter Regarding Article 'Heart failure in adults with congenital heart disease'.
Int J Cardiol. 2022 Aug 24. pii: S0167-5273(22)01255.
PubMed

OGAWA M, Yoshida N, Nakai M, Kanaoka K, et al
Hospital-associated disability and hospitalization costs for acute heart failure stratified by body mass index- insight from the JROAD/JROAD-DPC database.
Int J Cardiol. 2022 Aug 24. pii: S0167-5273(22)01254.
PubMed Abstract available

GHAJAR A, Ordonez CP, Philips B, Pinzon PQ, et al
Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes.
Int J Cardiol. 2022 Aug 21. pii: S0167-5273(22)01253.
PubMed Abstract available

LI S, Zheng Y, Huang Y, He W, et al
Association of body mass index and prognosis in patients with HFpEF: A dose-response meta-analysis.
Int J Cardiol. 2022;361:40-46.
PubMed Abstract available

PAPANASTASIOU CA, Bazmpani MA, Kokkinidis DG, Zegkos T, et al
The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysis.
Int J Cardiol. 2022 Aug 9. pii: S0167-5273(22)01175.
PubMed Abstract available

TSCHOPE C, Nelki V, Trippel TD, Klingel K, et al
Safety and usefulness of left ventricular endomyocardial biopsy in new- onset acute heart failure requiring mechanical support by an Impella(R) device.
Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01176.
PubMed Abstract available

GARATTI L, Frea S, Bocchino PP, Angelini F, et al
Sodium nitroprusside in acute heart failure: A multicenter historic cohort study.
Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01177.
PubMed Abstract available

LIM HS
How does protocolization improve outcomes in cardiogenic shock due to end-stage heart failure?
Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01115.
PubMed Abstract available

AIMO A, Lupon J, Spitaleri G, Domingo M, et al
Global warming, renal function and heart failure over 20years.
Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01113.
PubMed Abstract available

July 2022

TANG SS, Wang XJ, Tang CK
The authors' reply to the letter "CA125 a cause or an effect in heart failure?"
Int J Cardiol. 2022 Jul 31. pii: S0167-5273(22)01114.
PubMed

CHISHIKI T, Nagatomo Y, Saji M, Takei M, et al
Divergent effect of blood glucose dysregulation on long-term clinical outcome in acute decompensated heart failure: A reappraisal in contemporary practice.
Int J Cardiol. 2022 Jul 25. pii: S0167-5273(22)01111.
PubMed Abstract available

PINTALHAO M, Vasques-Novoa F, Couto-Viana B, Pimentel MJ, et al
Relaxin-2, pathophysiological insights and outcomes in heart failure with preserved ejection fraction: Findings from the NETDiamond cohort.
Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01106.
PubMed Abstract available

AREVALO-LORIDO JC, Carretero-Gomez J
The circular pathway for the improvement of readmitting heart failure patients.
Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01099.
PubMed

AUSTIN DE, Lee DS, Wang CX, Ma S, et al
Comparison of machine learning and the regression-based EHMRG model for predicting early mortality in acute heart failure.
Int J Cardiol. 2022 Jul 19. pii: S0167-5273(22)01105.
PubMed Abstract available

GODINO C, Scotti A, Marengo A, Battini I, et al
Effectiveness and cost-efficacy of diuretics home administration via peripherally inserted central venous catheter in patients with end-stage heart failure.
Int J Cardiol. 2022 Jul 16. pii: S0167-5273(22)01095.
PubMed Abstract available

MOOLLA M, Mathew A, John K, Yogasundaram H, et al
Outcomes of pregnancy in women with hypertrophic cardiomyopathy: A systematic review.
Int J Cardiol. 2022;359:54-60.
PubMed Abstract available

CHENG B, Zhong JP, Fu WJ, Chen HJ, et al
Microfiber-associated protein 5 (MFAP5): A promising approach to discover new biomarkers for heart failure and cardiac remodeling.
Int J Cardiol. 2022 Jul 7. pii: S0167-5273(22)01033.
PubMed

SHAMAKI GR, Kesiena O, Markson F, Andrew M, et al
Editorial of "Heart failure with normal LVEF in BIOSTAT-CHF" to International Journal of Cardiology".
Int J Cardiol. 2022 Jul 1. pii: S0167-5273(22)01021.
PubMed

SWARTZ AM, Wamsley C, Crownover E, Tarima S, et al
Move more and sit less pilot intervention for individuals with heart failure.
Int J Cardiol. 2022 Jul 1. pii: S0167-5273(22)01023.
PubMed Abstract available

June 2022

YANO M, Nishino M, Ukita K, Kawamura A, et al
Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction.
Int J Cardiol. 2022 Jun 29. pii: S0167-5273(22)01014.
PubMed Abstract available

YOUNES AM, Salem M, Maraey A, Nomigolzar S, et al
Safety outcomes of SGLT2i in the heart failure trials: A systematic review and Meta-analysis.
Int J Cardiol. 2022 Jun 28. pii: S0167-5273(22)01012.
PubMed Abstract available

BAUDO M, D'Ancona G, Trinca F, Rosati F, et al
Atrioventricular node ablation and pacing for atrial tachyarrhythmias: A meta-analysis of postoperative outcomes.
Int J Cardiol. 2022 Jun 25. pii: S0167-5273(22)01011.
PubMed Abstract available

RABKIN SW
Heart failure with reduced ejection fraction and diastolic dysfunction (HrEFwDD): Time for a new clinical entity.
Int J Cardiol. 2022 Jun 24. pii: S0167-5273(22)01008.
PubMed

KIM SE, Cho DH, Son JW, Kim JY, et al
Impact of NT-proBNP on prognosis of acute decompensated chronic heart failure versus de novo heart failure.
Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01007.
PubMed Abstract available

COWIE MR, Mourilhe-Rocha R, Chang HY, Volterrani M, et al
The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE heart failure care network.
Int J Cardiol. 2022 Jun 21. pii: S0167-5273(22)00922.
PubMed Abstract available

EPSTEIN E, Schale S, Brambatti M, You H, et al
Impact of Transitioning Patients to Oral Diuretics 24 Hours Before Discharge from Heart Failure Hospitalization on 30 Day Outcomes.
Int J Cardiol. 2022 Jun 20. pii: S0167-5273(22)00930.
PubMed Abstract available

CANEPA M, Leporatti L, Persico L, Ameri P, et al
Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy.
Int J Cardiol. 2022 Jun 18. pii: S0167-5273(22)00951.
PubMed Abstract available

IMRAN TF, Mohebali D, Lopez D, Goli RR, et al
NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy.
Int J Cardiol. 2022;357:48-54.
PubMed Abstract available

QIAN Z, Qin C, Zou F, Xue S, et al
Complete electrical reverse remodeling of native conduction after resynchronization therapies.
Int J Cardiol. 2022;357:81-87.
PubMed Abstract available

SEIDEL F, Opgen-Rhein B, Rentzsch A, Boehne M, et al
Clinical characteristics and outcome of biopsy-proven myocarditis in children - Results of the German prospective multicentre registry "MYKKE".
Int J Cardiol. 2022;357:95-104.
PubMed Abstract available

JOURY A, Ventura H, Krim SR
Biomarkers in heart failure: Relevance in the clinical practice.
Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00935.
PubMed Abstract available

KIM CH, Hwang IC, Choi HM, Ahn CH, et al
Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus.
Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00927.
PubMed Abstract available

DE LANGE I, Petersen TB, de Bakker M, Akkerhuis KM, et al
Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study).
Int J Cardiol. 2022 Jun 14. pii: S0167-5273(22)00919.
PubMed Abstract available

SHANG L, Sun H, Tang B, Hou Y, et al
Metabolic disorders as growing risk factors and comorbidities in heart failure.
Int J Cardiol. 2022 Jun 2. pii: S0167-5273(22)00822.
PubMed

IKEDA S, Shinohara K, Enzan N, Matsushima S, et al
Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease.
Int J Cardiol. 2022;356:98-104.
PubMed Abstract available

SABATINO J, Di Salvo G
The new pandemic: ACHD HF.
Int J Cardiol. 2022;356:51-52.
PubMed

May 2022

LEE SY, Jung MH
Sex-related differences among young adults with heart failure: Does sex matter?
Int J Cardiol. 2022 May 31. pii: S0167-5273(22)00808.
PubMed

HE S, Zhu H, Zhang J, Wu X, et al
Proteomic analysis of epicardial adipose tissue from heart disease patients with concomitant heart failure with preserved ejection fraction.
Int J Cardiol. 2022 May 31. pii: S0167-5273(22)00814.
PubMed Abstract available

BAUMHOVE L, Tromp J, Figarska S, van Essen BJ, et al
Heart failure with normal LVEF in BIOSTAT-CHF.
Int J Cardiol. 2022 May 29. pii: S0167-5273(22)00765.
PubMed Abstract available

RIBEIRO GDS, Deresz LF, Salvioni E, Hansen D, et al
Sensitivity and specificity of different exercise oscillatory ventilation definitions to predict 2-year major adverse cardiovascular outcomes in chronic heart failure patients.
Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00753.
PubMed Abstract available

LIMD Z, LiMD S
CA125 a cause or an effect in heart failure?
Int J Cardiol. 2022 May 23. pii: S0167-5273(22)00760.
PubMed

MOHAMMED SA
Editorial: Left, but not right, ventricular status determines heart failure in adults with Ebstein anomaly- a case-control study based on magnetic resonance.
Int J Cardiol. 2022 May 19. pii: S0167-5273(22)00749.
PubMed

STASSEN J, Khidir M, Galloo X, Hirasawa K, et al
Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
Int J Cardiol. 2022;355:65-71.
PubMed Abstract available

IWATSU K, Ikeda T, Matsumura K, Ashikawa H, et al
Gap in the prognostic impact of short physical performance battery among phenotypes of heart failure.
Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00656.
PubMed Abstract available

ANGUITA E, Chaparro A, Candel FJ, Ramos-Acosta C, et al
Biomarkers of stable and decompensated phases of heart failure with preserved ejection fraction.
Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00655.
PubMed Abstract available

April 2022

FRIGELLI M, Sturla F, Milani V, Ramputi L, et al
Prognostic value of left atrial strain quantification from 2D ultrasound imaging in post-ischemic heart failure patients: evidence from the REMODEL-HF study.
Int J Cardiol. 2022 Apr 30. pii: S0167-5273(22)00633.
PubMed Abstract available

BASIC C, Rosengren A, Dahlstrom U, Edner M, et al
Sex-related differences among young adults with heart failure in Sweden.
Int J Cardiol. 2022 Apr 28. pii: S0167-5273(22)00635.
PubMed Abstract available

CIARDULLO S, Cannistraci R, Mazzetti S, Mortara A, et al
Twenty-year trends in heart failure among U.S. adults, 1999-2018: The growing impact of obesity and diabetes.
Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00578.
PubMed Abstract available

YU X
Heart failure with improved ejection fraction: The current and future in Asian populations.
Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00579.
PubMed

CIEPLUCHA A, Trojnarska O, Rajewska-Tabor J, Bartczak-Rutkowska A, et al
Left, but not right, ventricular status determines heart failure in adults with Ebstein anomaly - A case-control study based on magnetic resonance.
Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00585.
PubMed Abstract available

LI L, Zhang Z, Xiong Y, Hu Z, et al
Prediction of hospital mortality in mechanically ventilated patients with congestive heart failure using machine learning approaches.
Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00581.
PubMed Abstract available

BERGONTI M, Spera F, Tijskens M, Bonomi A, et al
A new prediction model for left ventricular systolic function recovery after catheter ablation of atrial fibrillation in patients with heart failure.
Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00554.
PubMed Abstract available

CASTIGLIONE V, Vergaro G, Emdin M
Targeting precipitants to prevent heart failure hospitalization. Does season matter?
Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00561.
PubMed

RIZZO M, Cianflone D, Maranta F
Treatment of diabetes and heart failure: Facts and hopes.
Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00549.
PubMed

YALCIN YC, Veenis JF, Brugts JJ, Antonides CFJ, et al
Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantation.
Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00555.
PubMed Abstract available

ELBADAWI A, Tan BE, Assaf Y, Megaly M, et al
Digital health intervention in patients with recent hospitalization for acute heart failure: A systematic review and meta-analysis of randomized trials.
Int J Cardiol. 2022 Apr 15. pii: S0167-5273(22)00553.
PubMed Abstract available

SHOJI S, Kohsaka S, Shiraishi Y, Kohno T, et al
Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trials.
Int J Cardiol. 2022 Apr 11. pii: S0167-5273(22)00500.
PubMed Abstract available

MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
PubMed Abstract available

ROSENTHAL LL, Ulrich SM, Zimmerling L, Brenner P, et al
Pediatric heart transplantation in infants and small children under 3years of age: Single center experience - "Early and long-term results".
Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00482.
PubMed Abstract available

FERREIRA JP, Shah AM, Claggett BL, Pitt B, et al
Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-Americas.
Int J Cardiol. 2022;352:78-83.
PubMed Abstract available

March 2022

SENGUPTA SP, Okwose NC, MacGowan GA, Jakovljevic DG, et al
Peak atrio-ventricular mechanics predicts exercise tolerance in heart failure patients.
Int J Cardiol. 2022 Mar 31. pii: S0167-5273(22)00442.
PubMed Abstract available

SU K, Li M, Wang L, Tian S, et al
Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction.
Int J Cardiol. 2022 Mar 23. pii: S0167-5273(22)00405.
PubMed Abstract available

SATO T, Kobayashi Y, Nagai T, Nakatani T, et al
Long-term preservation of functional capacity and quality of life in advanced heart failure patients with bridge to transplant therapy: A report from Japanese nationwide multicenter registry.
Int J Cardiol. 2022 Mar 22. pii: S0167-5273(22)00403.
PubMed Abstract available

ZHANG Y
Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
Int J Cardiol. 2022 Mar 18. pii: S0167-5273(22)00389.
PubMed

ESPERSEN C, Modin D, Platz E, Jensen GB, et al
Global and regional wall motion abnormalities and incident heart failure in the general population.
Int J Cardiol. 2022 Mar 15. pii: S0167-5273(22)00386.
PubMed Abstract available

AIMO A, Lupon J, Bayes-Genis A, Emdin M, et al
Urinary NGAL in acute heart failure revisited: the game is not over yet.
Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00382.
PubMed

MINISTRINI S
Could serum carboxyterminal telopeptide of collagen type I (CITP) have a role in the early diagnosis of heart failure with preserved ejection fraction (HFpEF)?
Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00383.
PubMed

JAYAGOPAL PB, Sastry SL, Nanjappa V, Abdullakutty J, et al
Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR).
Int J Cardiol. 2022 Mar 13. pii: S0167-5273(22)00381.
PubMed Abstract available

BRIDA M, Lovric D, Griselli M, Gil FR, et al
Heart failure in adults with congenital heart disease.
Int J Cardiol. 2022 Mar 10. pii: S0167-5273(22)00337.
PubMed Abstract available

BILLINGSLEY HE, Canada JM, Dixon DL, Kirkman DL, et al
Midpoint of energy intake, non-fasting time and cardiorespiratory fitness in heart failure with preserved ejection fraction and obesity.
Int J Cardiol. 2022 Mar 8. pii: S0167-5273(22)00330.
PubMed Abstract available

February 2022

HORIUCHI Y, Wettersten N, van Veldhuisen DJ, Mueller C, et al
Decongestion, kidney injury and prognosis in patients with acute heart failure.
Int J Cardiol. 2022 Feb 21. pii: S0167-5273(22)00261.
PubMed Abstract available

CHIANG B, Chew DP, De Pasquale CG
Outcome trial data on sodium glucose cotransporter-2 inhibitors: Putting clinical benefits and risks in perspective.
Int J Cardiol. 2022;349:96-98.
PubMed Abstract available

TINI G, Cuomo A, Battistoni A, Sarocchi M, et al
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice.
Int J Cardiol. 2022;349:134-137.
PubMed Abstract available

ROJAS LZ, Gomez-Ochoa SA, Echeverria LE, Bautista-Nino PK, et al
Circulating DHEA-S levels and major cardiovascular outcomes in chronic Chagas cardiomyopathy: A prospective cohort study.
Int J Cardiol. 2022;349:90-95.
PubMed Abstract available

MANTOVANI A, Bonapace S, Dugo C, Beatrice G, et al
Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
Int J Cardiol. 2022 Feb 12. pii: S0167-5273(22)00248.
PubMed Abstract available

DURAN A, De Anda-Duran I, Ventura HO
The era of heart failure risk prediction models, is it time to test their utility?
Int J Cardiol. 2022 Feb 9. pii: S0167-5273(22)00218.
PubMed

CHARANSONNEY OL
SGLT-2 inhibitors in frail patients with heart failure.
Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00193.
PubMed

GIRERD N
The growing importance of heart failure in myocardial infarction.
Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00194.
PubMed

SALA A, Lorusso R, Alfieri O
Isolated tricuspid regurgitation: A plea for early correction.
Int J Cardiol. 2022 Feb 4. pii: S0167-5273(22)00195.
PubMed Abstract available

TRAMBAIOLO P, Figliuzzi I, Salvati M, Bertini P, et al
Ventriculo-arterial coupling in the intensive cardiac care unit: A non-invasive prognostic parameter.
Int J Cardiol. 2022;348:85-89.
PubMed Abstract available

AHMED S, Ahmed A, Radegran G
The Authors' Reply to the Letter "Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis".
Int J Cardiol. 2022;348:108.
PubMed

January 2022

ROVAI S, Contini M, Sciomer S, Vignati C, et al
The double anaerobic threshold in heart failure.
Int J Cardiol. 2022 Jan 25. pii: S0167-5273(22)00136.
PubMed Abstract available

DONAL E, L'official G, Kosmala W
New guidelines for managing chronic heart failure patients and new needs in echocardiography.
Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00125.
PubMed

SCRUTINIO D, Guida P, Passantino A, Scalvini S, et al
Association of improvement in functional capacity after rehabilitation with long-term survival in heart failure.
Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00129.
PubMed Abstract available

CHANG GM, Chen JY, Kuo WY, Tung YC, et al
Associations of continuity and coordination of care with outcomes and costs after discharge among patients with heart failure: A nationwide population-based study.
Int J Cardiol. 2022 Jan 19. pii: S0167-5273(22)00118.
PubMed Abstract available

ZHENG H, Liang J, Chen X, Chen X, et al
Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis.
Int J Cardiol. 2022;347:64-65.
PubMed

CARLUCCIO E, Dini FL, Bitto R, Ciccarelli M, et al
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study.
Int J Cardiol. 2022 Jan 5. pii: S0167-5273(22)00004.
PubMed Abstract available

GIANNONI A, Sciarrone P
Prognostic impact of diabetes in heart failure: looking back to move forward.
Int J Cardiol. 2022 Jan 4. pii: S0167-5273(22)00005.
PubMed

December 2021

DRISCOLL A, Romanuick H, Dinh D, Amerena J, et al
Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure.
Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02053.
PubMed Abstract available

GIACCARI A, Pontremoli R, Filardi PP
SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.
Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02054.
PubMed Abstract available

RIND IA, Cannata A, McDonaugh B, Cassimon B, et al
Patients hospitalised with heart failure across different waves of the COVID-19 pandemic show consistent clinical characteristics and outcomes.
Int J Cardiol. 2021 Dec 29. pii: S0167-5273(21)02045.
PubMed Abstract available

DE LUCA L, Cicala SD, D'Errigo P, Cerza F, et al
Impact of age, gender and heart failure on mortality trends after acute myocardial infarction in Italy.
Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02015.
PubMed Abstract available

BHATIA HS, Nishimura M, Martinez A, Vanam S, et al
Systolic dysfunction in patients with methamphetamine use and heart failure with preserved ejection fraction.
Int J Cardiol. 2021 Dec 15. pii: S0167-5273(21)02016.
PubMed Abstract available

ANABA U, Ishola A, Alabre A, Bui A, et al
Diversity in modern heart failure trials: Where are we, and where are we going.
Int J Cardiol. 2021 Dec 14. pii: S0167-5273(21)02010.
PubMed Abstract available

BALBI C
Editorial: Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
Int J Cardiol. 2021 Dec 13. pii: S0167-5273(21)01995.
PubMed

GUAZZI M, Bursi F, Rusconi F
Lung Biomarkers: a new route for distinguishing pulmonary hypertension due to HFpEF from pulmonary arterial hypertension.
Int J Cardiol. 2021 Dec 13. pii: S0167-5273(21)01982.
PubMed

YANDRAPALLI S, Malik AH, Namrata F, Pemmasani G, et al
Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations.
Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01976.
PubMed Abstract available

SARDU C, Amarelli C
Continuous flow left ventricular assist devices and cardiac resynchronization: Friends or foe?
Int J Cardiol. 2021;344:138-139.
PubMed

LIANG Y, Ding R, Wang J, Gong X, et al
Prediction of response after cardiac resynchronization therapy with machine learning.
Int J Cardiol. 2021;344:120-126.
PubMed Abstract available

November 2021

KRIM SR
Use of plasma renin and aldosterone profiles for prognostication in acute heart failure: A step forward but not ready for prime time.
Int J Cardiol. 2021 Nov 30. pii: S0167-5273(21)01952.
PubMed

OSUNDOLIRE S, Naqvi S, Nunes AP, Lapane KL, et al
Heart failure among US nursing home residents with diabetes mellitus.
Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01777.
PubMed Abstract available

KITAI T
Early intravenous vasodilator therapy in acute decompensated heart failure: Is the time-to-treat concept still applicable in a pre-hospital setting?
Int J Cardiol. 2021 Nov 20. pii: S0167-5273(21)01859.
PubMed

REA F, Iorio A, Barbati G, Bessi R, et al
Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure.
Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01788.
PubMed

FUDIM M, Devaraj S, Chukwurah M, Ajam T, et al
Prognosis for patients with heart failure and reduced ejection fraction with and without diabetes: A 7 year nationwide veteran administration analysis.
Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01849.
PubMed Abstract available

LAMMERS AE, Sprenger KS, Diller GP, Miera O, et al
Ventricular assist devices in paediatric cardiomyopathy and congenital heart disease: An analysis of the German National Register for Congenital Heart Defects.
Int J Cardiol. 2021;343:37-44.
PubMed Abstract available

GORI M, Marini M, De Maria R, Gonzini L, et al
Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure.
Int J Cardiol. 2021 Nov 15. pii: S0167-5273(21)01783.
PubMed Abstract available

MO M, Xia N, Liao Y
Letter on "Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials".
Int J Cardiol. 2021 Nov 13. pii: S0167-5273(21)01839.
PubMed

TEMPORELLI PL, Arbelo E, Laroche C, Blomstrom-Lundqvist C, et al
Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry.
Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01779.
PubMed Abstract available

PFEIFER P, Zietzer A, Holscher M, Jehle J, et al
Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01772.
PubMed Abstract available

UDANI K, Chris-Olaiya A, Ohadugha C, Malik A, et al
Cardiovascular manifestations in hospitalized patients with hemochromatosis in the United States.
Int J Cardiol. 2021;342:117-124.
PubMed Abstract available

FASTNER C, Yuecel G, Rudic B, Schmiel G, et al
Cardiac Contractility Modulation in Patients with Ischemic versus Non-ischemic Cardiomyopathy: Results from the MAINTAINED Observational Study.
Int J Cardiol. 2021;342:49-55.
PubMed Abstract available

October 2021

BIEGUS J, Nawrocka-Millward S, Zymlinski R, Fudim M, et al
Distinct renin/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure.
Int J Cardiol. 2021 Oct 30. pii: S0167-5273(21)01703.
PubMed Abstract available

AHMED S, Ahmed A, Radegran G
Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension.
Int J Cardiol. 2021 Oct 25. pii: S0167-5273(21)01690.
PubMed Abstract available

HE Z, Yang L, Nie Y, Wang Y, et al
Effects of SGLT-2 inhibitors on health-related quality of life and exercise capacity in heart failure patients with reduced ejection fraction: A systematic review and meta-analysis.
Int J Cardiol. 2021 Oct 12. pii: S0167-5273(21)01562.
PubMed Abstract available

YOUN JC, Baek SH
Heart failure risk in younger adults needing more attention.
Int J Cardiol. 2021 Oct 8. pii: S0167-5273(21)01560.
PubMed

ARENJA N, Mueller C, Tomilovskaya E, Koryak Y, et al
Real-world experience of feasibility and efficacy of electrical muscle stimulation in elderly patients with acute heart failure: A randomized controlled study.
Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01504.
PubMed Abstract available

DARDEN D, Ammirati E, Brambatti M, Lin A, et al
Cardiovascular implantable electronic device therapy in patients with left ventricular assist devices: insights from TRAViATA.
Int J Cardiol. 2021;340:26-33.
PubMed Abstract available

September 2021

MIRO O, Llorens P, Freund Y, Davison B, et al
Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry.
Int J Cardiol. 2021 Sep 17. pii: S0167-5273(21)01470.
PubMed Abstract available

DLOUHA D, Ivak P, Netuka I, Novakova S, et al
The effect of long-term left ventricular assist device support on flow-sensitive plasma microRNA levels.
Int J Cardiol. 2021;339:138-143.
PubMed Abstract available

WEBER C, Hung J, Hickling S, Li I, et al
Changing age-specific trends in incidence, comorbidities and mortality of hospitalised heart failure in Western Australia between 2001 and 2016.
Int J Cardiol. 2021 Sep 11. pii: S0167-5273(21)01376.
PubMed Abstract available

KAPELIOS CJ, Canepa M, Benson L, Hage C, et al
Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: Observations from The Swedish Heart Failure Registry.
Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01334.
PubMed Abstract available

GUIMARAES GV, Ribeiro F, Castro RE, Roque JM, et al
Effects of the exercise training on skeletal muscle oxygen consumption in heart failure patients with reduced ejection fraction.
Int J Cardiol. 2021 Sep 7. pii: S0167-5273(21)01318.
PubMed Abstract available

AMARELLI C, Limongelli G
Cardiac amyloidosis: Watching the tip of the iceberg emerging from the "heart of the sea".
Int J Cardiol. 2021;338:226-228.
PubMed

BODE N, Hochadel M, Andresen D, Zahn R, et al
Cardiac glycosides are not associated with increased mortality or hospitalization rates in ICD and CRT-ICD patients after adjustment for baseline-characteristics at one-year follow-up: Results from the German DEVICE registry.
Int J Cardiol. 2021;338:109-114.
PubMed Abstract available

August 2021

MONZO L, Ferrari I, Cicogna F, Tota C, et al
Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction.
Int J Cardiol. 2021 Aug 26. pii: S0167-5273(21)01301.
PubMed Abstract available

KANEKO H, Itoh H, Kamiya K, Morita K, et al
Acute-phase initiation of cardiac rehabilitation and clinical outcomes in hospitalized patients for acute heart failure.
Int J Cardiol. 2021 Aug 26. pii: S0167-5273(21)01307.
PubMed Abstract available

NAKAO K, Yasuda S, Noguchi T, Sumita Y, et al
Association of hospital performance measures with readmissions for patients with heart failure: A report from JROAD-DPC study.
Int J Cardiol. 2021 Aug 19. pii: S0167-5273(21)01229.
PubMed Abstract available

VINTER N, Frost L, Benjamin EJ
Heart failure and atrial fibrillation - does heart failure subtype matter?
Int J Cardiol. 2021 Aug 6. pii: S0167-5273(21)01216.
PubMed

TADA A, Nagai T, Omote K, Iwano H, et al
Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry.
Int J Cardiol. 2021 Aug 5. pii: S0167-5273(21)01211.
PubMed Abstract available

July 2021

MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
PubMed Abstract available

ABBOUD A, Gaggin HK
Heart failure and frailty: Expanding the gender paradox.
Int J Cardiol. 2021 Jul 24. pii: S0167-5273(21)01190.
PubMed

ZHOU Y, Chen S, Rao Z, Yang D, et al
Prediction of 1-year mortality after heart transplantation using machine learning approaches: A single-center study from China.
Int J Cardiol. 2021 Jul 13. pii: S0167-5273(21)01169.
PubMed Abstract available

NJI MAM, Solomon SD, Chen LY, Shah AM, et al
Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.
Int J Cardiol. 2021 Jul 8. pii: S0167-5273(21)01100.
PubMed Abstract available

VALERIANOVA A, Malik J, Janeckova J, Kovarova L, et al
Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients.
Int J Cardiol. 2021;334:148-153.
PubMed Abstract available

June 2021

DE LA ESPRIELLA R, Minana G, Santas E, Nunez G, et al
Effects of empagliflozin on CA125 trajectory in patients with chronic congestive heart failure.
Int J Cardiol. 2021 Jun 30. pii: S0167-5273(21)01084.
PubMed Abstract available

ISHIWATA S, Matsue Y, Nakamura Y, Dotare T, et al
Clinical and prognostic values of urinary alpha1-microglobulin as a tubular marker in acute heart failure.
Int J Cardiol. 2021 Jun 26. pii: S0167-5273(21)01079.
PubMed Abstract available

DURAN A, daSilva-deAbreu A, Joury A, Ventura HO, et al
FGF23 predicts outcomes in heart failure but questions remain unanswered.
Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01034.
PubMed

ILONZE OJ, Guglin M
Vericiguat, organic nitrates, and heart failure in African Americans.
Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01031.
PubMed Abstract available

DOLDI PM, Buech J, Orban M, Samson-Himmelstjerna P, et al
Transcatheter mitral valve repair may increase eligibility for heart transplant listing in patients with end-stage heart failure and severe secondary mitral regurgitation.
Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01029.
PubMed Abstract available

KEULARDS DCJ, Bouwmeester S, de Vos AMJ, Dekker LRC, et al
High microvascular resistance and reduced left atrial strain in patients with coronary microvascular dysfunction: The micro-strain study.
Int J Cardiol. 2021;333:21-28.
PubMed Abstract available

DASILVA-DEABREU A, Lavie CJ, Mehra MR
Bridging the palliative care chasm in advanced heart failure.
Int J Cardiol. 2021 Jun 15. pii: S0167-5273(21)00969.
PubMed

WANG M, Luo B
Levosimendan is safe to patients with advanced heart failure and hypotension.
Int J Cardiol. 2021 Jun 9. pii: S0167-5273(21)00914.
PubMed

EMOTO T, Hayashi T, Tabata T, Yamashita T, et al
Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
Int J Cardiol. 2021 Jun 5. pii: S0167-5273(21)00962.
PubMed Abstract available

LIU L, Lima JAC, Post WS, Szklo M, et al
Associations of time-varying obesity and metabolic syndrome with risk of incident heart failure and its subtypes: Findings from the Multi-Ethnic Study of Atherosclerosis.
Int J Cardiol. 2021 Jun 2. pii: S0167-5273(21)00908.
PubMed Abstract available

POTRATZ M, Fox H, Rudolph V, Faber L, et al
Respiratory dyssynchrony is a predictor of prognosis in patients with hypertrophic non-obstructive cardiomyopathy.
Int J Cardiol. 2021;332:105-112.
PubMed Abstract available

May 2021

AIMO A
Longitudinal changes in cardiac biomarkers and outcome in heart failure: Sex-related differences.
Int J Cardiol. 2021 May 18. pii: S0167-5273(21)00839.
PubMed

VERGARO G, Aimo A, Taurino E, Del Franco A, et al
Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure.
Int J Cardiol. 2021 May 18. pii: S0167-5273(21)00840.
PubMed Abstract available

SAMUEL TJ, Wei J, Sharif B, Tamarappoo BK, et al
Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging.
Int J Cardiol. 2021;331:1-7.
PubMed Abstract available

GALLI E, Smiseth OA MD, PhD, Aalen JM, Larsen CK, et al
Prognostic utility of the assessment of diastolic function in patients undergoing cardiac resynchronization therapy.
Int J Cardiol. 2021;331:144-151.
PubMed Abstract available

MACGOWAN GA, Woods A, Robinson-Smith N, Tovey S, et al
Using existing technology better: Improving outcomes with the HeartWare left ventricular assist device.
Int J Cardiol. 2021;331:35-39.
PubMed Abstract available

SHARIATI F, Baldawi H, Bob-Manuel T
Editorial: Premature death from heart failure among Aboriginal peoples in the Hunter New England region of new South Wales.
Int J Cardiol. 2021 May 14. pii: S0167-5273(21)00838.
PubMed

KAMIYA K, Adachi T, Iwatsu K, Kamisaka K, et al
Association between a pre-admission limitation in walking ability and post-discharge adverse outcomes among hospitalized patients with heart failure: Report from a multicenter prospective cohort study.
Int J Cardiol. 2021 May 12. pii: S0167-5273(21)00832.
PubMed Abstract available

SACCO A, Morici N, Villanova L, Viola G, et al
Withdrawal of active treatments in terminally ill heart failure patients.
Int J Cardiol. 2021 May 5. pii: S0167-5273(21)00815.
PubMed Abstract available

KLEIN HU
Cardiac resynchronization therapy with- or without defibrillator. Estimating the risk of arrhythmic death or assessing the likelihood of non-arrhythmic mortality?
Int J Cardiol. 2021;330:82-83.
PubMed

April 2021

SCHREUDER MM, Schuurman A, Akkerhuis KM, Constantinescu AA, et al
Sex-specific temporal evolution of circulating biomarkers in patients with chronic heart failure with reduced ejection fraction.
Int J Cardiol. 2021 Apr 30. pii: S0167-5273(21)00804.
PubMed Abstract available

GORI M, Claggett B, Senni M, Shah AM, et al
Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction.
Int J Cardiol. 2021 Apr 19. pii: S0167-5273(21)00664.
PubMed Abstract available

AIMO A, Manetti S, Emdin M
How much is it to mend a broken heart? Results from the US Nationwide Readmission Database.
Int J Cardiol. 2021;329:150-151.
PubMed

MCGEE M, Sugito S, Al-Omary MS, Hartnett D, et al
Heart failure outcomes in Aboriginal and Torres Strait Islander peoples in the Hunter New England region of New South Wales.
Int J Cardiol. 2021 Apr 8. pii: S0167-5273(21)00637.
PubMed Abstract available

LI X, Zhang Q, Zhu L, Wang G, et al
Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials.
Int J Cardiol. 2021 Apr 7. pii: S0167-5273(21)00636.
PubMed Abstract available

CAO M, Stolen CM, Ahmed R, Schloss EJ, et al
Small decreases in biventricular pacing percentages are associated with multiple metrics of worsening heart failure as measured from a cardiac resynchronization therapy defibrillator.
Int J Cardiol. 2021 Apr 1. pii: S0167-5273(21)00632.
PubMed Abstract available

QAMRUDDIN S, Ventura HO
Serial echocardiographic parameters to evaluate prognosis in patients with HFrEF - is it worth the second test?
Int J Cardiol. 2021;328:141-142.
PubMed

REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis.
Int J Cardiol. 2021;328:46-54.
PubMed Abstract available

COHEN ARAZI H, Chirino D, Costabel JP, Pulmari CA, et al
Leuko-platelet index predicts thrombotic events in patients with acute coronary syndrome.
Int J Cardiol. 2021;328:29-34.
PubMed Abstract available

March 2021

JACKSON AO, Rahman GA, Long S
Attenuating senescence and dead cells accumulation as heart failure therapy: Break the communication networks.
Int J Cardiol. 2021 Mar 29. pii: S0167-5273(21)00565.
PubMed

SURKOVA E, Dimopoulos K, Li W
Reply to: "Systolic dysfunction of the subpulmonary left ventricle in the systemic right ventricle: late manifestation or subclinical predictor of heart failure?"
Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00621.
PubMed Abstract available

LAINSCAK M, Omersa D, Rosano G, Farkas J, et al
Pharmacotherapy adherence in patients with heart failure: Easier said than done.
Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00555.
PubMed

LI Y, Li L, Wang C
Insulin-like growth factor binding protein 2 might be a novel therapeutic target in the treatment of heart failure.
Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00549.
PubMed

COHEN S, Liu A, Abrahamowicz M, Brophy JM, et al
Reply to "Risk prediction models for heart failure admissions in adults with congenital heart disease: Methodological issues".
Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00482.
PubMed

TANG L, Liu J, Zheng J
Targeting mitochondrial calcium uniporter in heart failure.
Int J Cardiol. 2021 Mar 16. pii: S0167-5273(21)00485.
PubMed

AL-WAKEEL-MARQUARD N, Seidel F, Herbst C, Kuhnisch J, et al
Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
Int J Cardiol. 2021 Mar 15. pii: S0167-5273(21)00480.
PubMed Abstract available

GHIO S, Carluccio E, Scardovi AB, Dini FL, et al
Prognostic relevance of Doppler echocardiographic re-assessment in HFrEF patients.
Int J Cardiol. 2021;327:111-116.
PubMed Abstract available

KOCHAV SM, Raita Y, Fifer MA, Takayama H, et al
Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
Int J Cardiol. 2021;327:117-124.
PubMed Abstract available

CARLUCCIO E, Pugliese NR, Biagioli P, Zuchi C, et al
Global longitudinal strain in heart failure with reduced ejection fraction: Prognostic relevance across disease severity as assessed by automated cluster analysis.
Int J Cardiol. 2021 Mar 10. pii: S0167-5273(21)00383.
PubMed Abstract available

HIGUCHI S, Shibata S, Hasegawa H, Matsuda T, et al
Reply to the letter to the editor: "Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia".
Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00458.
PubMed

STIENEN S, Ferreira JP, Bar C, Thum T, et al
Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.
Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00399.
PubMed Abstract available

BARISON A, Aimo A, Emdin M
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset.
Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00387.
PubMed

OLSEN FJ, Biering-Sorensen T
Right atrial strain: Tapping into a new reservoir of hemodynamic information.
Int J Cardiol. 2021;326:226-228.
PubMed

YEUNG DF, Jiang R, Behnami D, Jue J, et al
Impact of the updated diastolic function guidelines in the real world.
Int J Cardiol. 2021;326:124-130.
PubMed Abstract available

SAVIRA F, Kompa AR, Edgley AJ, Jucker BM, et al
RE: Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis.
Int J Cardiol. 2021;326:156.
PubMed

February 2021

DAVIS MR, Lee CS, Corcoran A, Gupta N, et al
Gender differences in the prevalence of frailty in heart failure: A systematic review and meta-analysis.
Int J Cardiol. 2021 Feb 28. pii: S0167-5273(21)00371.
PubMed Abstract available

NITTA G, Inaba O, Kato S, Kono T, et al
Catheter ablation for atrial fibrillation in patients with congestive heart failure.
Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00369.
PubMed Abstract available

PAOLILLO S, Salvioni E, Perrone Filardi P, Bonomi A, et al
Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652].
Int J Cardiol. 2021 Feb 25. pii: S0167-5273(21)00354.
PubMed

VAN DEN EYNDE J, Santens B, Van De Bruaene A, Budts W, et al
Systolic dysfunction of the subpulmonary left ventricle in the systemic right ventricle: Late manifestation or subclinical predictor of heart failure?
Int J Cardiol. 2021 Feb 25. pii: S0167-5273(21)00368.
PubMed

RAJDEV K, Lahan S, Wichman T
Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis.
Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00296.
PubMed Abstract available

ELBADAWI A, Dang A, Elgendy IY, Thakker R, et al
Age-specific trends and outcomes of hospitalizations with acute heart failure in the United States.
Int J Cardiol. 2021 Feb 17. pii: S0167-5273(21)00284.
PubMed Abstract available

HSIAO FC, Lin CP, Tung YC, Chang PC, et al
Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study.
Int J Cardiol. 2021 Feb 12. pii: S0167-5273(21)00288.
PubMed Abstract available

SCALVINI S, Bernocchi P, Villa S, Paganoni AM, et al
Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100,785 patients.
Int J Cardiol. 2021 Feb 11. pii: S0167-5273(21)00267.
PubMed Abstract available

PASSINO C, Sciarrone P, Vergaro G, Borrelli C, et al
Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction.
Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00263.
PubMed Abstract available

WANG X, Li X
Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia.
Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00269.
PubMed

SAKANE K, Kanzaki Y, Hoshiga M
Reply to "Clinical Significance of B-type Natriuretic Peptide in Patient with Acute Decompensated Heart Failure".
Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00272.
PubMed

LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
PubMed Abstract available

PROUDFOOT C, Studer R, Rajput T, Jindal R, et al
Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review.
Int J Cardiol. 2021 Feb 2. pii: S0167-5273(21)00143.
PubMed Abstract available

VERONESE G, Ammirati E, Chen C, Klingel K, et al
Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis.
Int J Cardiol. 2021;324:131-138.
PubMed Abstract available

January 2021

SHETTY S, Malik AH, Ali A, Yang YC, et al
Characteristics, trends, outcomes, and costs of stimulant-related acute heart failure hospitalizations in the United States.
Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00142.
PubMed Abstract available

NOURAEI H, Rabkin SW
A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
PubMed Abstract available

THEUNS DAMJ, Schaer BA, Caliskan K, Hoeks SE, et al
Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization defibrillators.
Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00091.
PubMed Abstract available

SABOUR S, Ghajari H
Risk prediction models for heart failure admissions in adults with congenital heart disease: Methodological issues.
Int J Cardiol. 2021 Jan 25. pii: S0167-5273(21)00083.
PubMed

CAMELI M, Pastore MC, Mandoli GE
Left atrial strain: A key element for the evaluation of patients with HFpEF.
Int J Cardiol. 2021;323:197-198.
PubMed

SAVIRA F, Edgley AJ, Jucker BM, Willette RN, et al
RE: Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.
Int J Cardiol. 2021;323:260.
PubMed

WEI WY, Lian ZX, Ji Y, Zhang N, et al
Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis.
Int J Cardiol. 2021;323:205.
PubMed

DANI SS, Ganatra S, Vaduganathan M
Angioedema with sacubitril/valsartan: Trial-level meta-analysis of over 14,000 patients and real-world evidence to date.
Int J Cardiol. 2021;323:188-191.
PubMed Abstract available

IZUMIDA T, Imamura T
Clinical significance of B-type natriuretic peptide in patient with acute decompensated heart failure.
Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34326.
PubMed

GALLO-BERNAL S, Calixto CA, Molano-Gonzalez N, Moreno MPD, et al
Impact of a pharmacist-based multidimensional intervention aimed at decreasing the risk of hyperkalemia in heart failure patients: A Latin-American experience.
Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34329.
PubMed Abstract available

KUMAR V, Ryu AJ, Manduca A, Rao C, et al
Cardiac MRI demonstrates compressibility in healthy myocardium but not in myocardium with reduced ejection fraction.
Int J Cardiol. 2021;322:278-283.
PubMed Abstract available

RYU AJ, Kumar V, Borlaug BA, Manduca A, et al
Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy.
Int J Cardiol. 2021;322:272-277.
PubMed Abstract available

December 2020

KAWADA T
Risk of heart failure and prognosis in patients with atrial fibrillation.
Int J Cardiol. 2020 Dec 31. pii: S0167-5273(20)34316.
PubMed

IMAMURA T
Therapeutic strategy for the patients with Takayasu arteritis and heart failure.
Int J Cardiol. 2020 Dec 31. pii: S0167-5273(20)34318.
PubMed

MAGGIONI AP
How to appropriately update practicing clinicians on innovations in heart failure therapy waiting for the new version of the guidelines?
Int J Cardiol. 2020 Dec 24. pii: S0167-5273(20)34290.
PubMed

PESTELLI G, Fiorencis A, Trevisan F, Luisi GA, et al
New measures of right ventricle-pulmonary artery coupling in heart failure: An all-cause mortality echocardiographic study.
Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34305.
PubMed Abstract available

AGARWAL A, Mohanan PP, Kondal D, Baldridge A, et al
Effect of a quality improvement intervention for acute heart failure in South India: An interrupted time series study.
Int J Cardiol. 2020 Dec 21. pii: S0167-5273(20)34296.
PubMed Abstract available

GAU SY
Confusing heart failure ischemic etiology prevalence trend and the definition of composite events.
Int J Cardiol. 2020 Dec 14. pii: S0167-5273(20)34276.
PubMed

KWOK CS, Abramov D, Parwani P, Ghosh RK, et al
Cost of inpatient heart failure care and 30-day readmissions in the United States.
Int J Cardiol. 2020 Dec 12. pii: S0167-5273(20)34268.
PubMed Abstract available

TAKAHAMA H, Izumi C
Palliative care for patients with advanced heart failure: When is the optimal timing of advanced care planning?
Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34251.
PubMed

VOLPE M, Bauersachs J, Bayes-Genis A, Butler J, et al
Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence.
Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34242.
PubMed Abstract available

SAKANE K, Kanzaki Y, Tsuda K, Maeda D, et al
Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction.
Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34235.
PubMed Abstract available

CHIONCEL O, Ambrosy AP
Improving adherence to guideline-directed medical therapies and outcomes in the developing world: A call to end global inequities in heart failure.
Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34230.
PubMed

PAN J, Wang L, Sun Y
Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.
Int J Cardiol. 2020;320:139.
PubMed

November 2020

FERNANDEZ-MARTINEZ J, Romero-Correa M, Salamanca-Bautista P, Aramburu-Bodas O, et al
Prevalence of advanced heart failure and use of palliative care in admitted patients: Findings from the EPICTER study.
Int J Cardiol. 2020 Nov 7. pii: S0167-5273(20)34076.
PubMed Abstract available

WANG Y, Tse G, Roever L, Liu T, et al
Sacubitril/valsartan in the treatment of cancer therapy-related cardiac dysfunction.
Int J Cardiol. 2020;318:130.
PubMed

October 2020

SCHWARTZ B, Schou M, Gislason GH, Kober L, et al
Prevalence and incidence of various cancer subtypes in patients with heart failure vs matched controls.
Int J Cardiol. 2020 Oct 31. pii: S0167-5273(20)34065.
PubMed

PUGLIESE NR, Rosada J, Masi S
Train the brain to preserve the heart: the link between education and heart failure.
Int J Cardiol. 2020 Oct 30. pii: S0167-5273(20)34057.
PubMed

RAVAL AN, Johnston PV, Duckers HJ, Cook TD, et al
Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
Int J Cardiol. 2020 Oct 19. pii: S0167-5273(20)33996.
PubMed Abstract available

ZHANG Y, Fan P, Zhang H, Ma W, et al
Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.
Int J Cardiol. 2020 Oct 18. pii: S0167-5273(20)33984.
PubMed Abstract available

HARIKRISHNAN S, Jeemon P, Ganapathi S, Agarwal A, et al
Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry.
Int J Cardiol. 2020 Oct 10. pii: S0167-5273(20)33921.
PubMed Abstract available

LEE SY, Kim HL, Kim MA, Park JJ, et al
Obesity paradox in Korean male and female patients with heart failure: A report from the Korean heart failure registry.
Int J Cardiol. 2020 Oct 9. pii: S0167-5273(20)33922.
PubMed Abstract available

SHARMA K, Premchand RK, Mittal S, Monteiro R, et al
Long-term follow-up of patients with heart failure and reduced ejection receiving autonomic regulation therapy in the ANTHEM-HF pilot study.
Int J Cardiol. 2020 Oct 7. pii: S0167-5273(20)33902.
PubMed Abstract available

PANA TA, Mohamed MO, Clark AB, Fahy E, et al
Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure.
Int J Cardiol. 2020 Oct 3. pii: S0167-5273(20)33906.
PubMed Abstract available

LIAO LZ, Zhuang XD, Zhang SZ, Liao XX, et al
Education and heart failure: New insights from the atherosclerosis risk in communities study and mendelian randomization study.
Int J Cardiol. 2020 Oct 2. pii: S0167-5273(20)33898.
PubMed Abstract available

ZHONG P, Yuan M, Kong B, Huang H, et al
ASK-1, a new target in treating cardiorenal syndrome (CRS).
Int J Cardiol. 2020;316:208.
PubMed

SAVIRA F, Kompa AR, Edgley AJ, Jucker BM, et al
RE: ASK1, a new target in treating cardiorenal syndrome (CRS).
Int J Cardiol. 2020;316:207.
PubMed

September 2020

SHIBATA N, Kondo T, Kazama S, Kimura Y, et al
Impact of predictive value of Fibrosis-4 index in patients hospitalized for acute heart failure.
Int J Cardiol. 2020 Sep 29. pii: S0167-5273(20)33837.
PubMed Abstract available

SURKOVA E, Segura T, Dimopouosl K, Bispo D, et al
Systolic dysfunction of the subpulmonary left ventricle is associated with the severity of heart failure in patients with a systemic right ventricle.
Int J Cardiol. 2020 Sep 25. pii: S0167-5273(20)33832.
PubMed Abstract available

AMMIRATI E, Brambatti M, Braun OO, Shah P, et al
Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA).
Int J Cardiol. 2020 Sep 17. pii: S0167-5273(20)33807.
PubMed Abstract available

BRIDA M
Heart transplantation in adult congenital heart disease: Importance of timely referral.
Int J Cardiol. 2020 Sep 14. pii: S0167-5273(20)33822.
PubMed

August 2020

MERAS P, Riesgo-Gil F, Rybicka J, Barradas-Pires A, et al
Heart transplantation at a single tertiary adult congenital heart disease centre: Too little, too late?
Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33574.
PubMed Abstract available

SANDERSON JE, Fang F
Cardiac cycle time intervals are back again.
Int J Cardiol. 2020;312:87-88.
PubMed

July 2020

ALKHALIL M, Kearney A, MacElhatton D, Fergie R, et al
The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction.
Int J Cardiol. 2020 Jul 15. pii: S0167-5273(20)33449.
PubMed Abstract available

April 2020

LEE EC, McNitt S, Martens J, Bruckel JT, et al
Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure.
Int J Cardiol. 2020 Apr 19. pii: S0167-5273(19)34902.
PubMed Abstract available

March 2020

GAVAZZONI M, Taramasso M, Zuber M, Pozzoli A, et al
Functional mitral regurgitation and cardiac resynchronization therapy in the "era" of trans-catheter interventions: Is it time to move from a staged strategy to a tailored therapy?
Int J Cardiol. 2020 Mar 28. pii: S0167-5273(19)35293.
PubMed Abstract available

February 2020

RASHID M, Curzen N, Kinnaird T, Lawson CA, et al
Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP.
Int J Cardiol. 2020;301:7-13.
PubMed Abstract available

LAHUERTA C, Menao S, Gracia-Gutierrez A, Bueno-Juana E, et al
Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
Int J Cardiol. 2020;301:220-225.
PubMed Abstract available

CAZZOLI I, Gunturiz-Beltran C, Guarguagli S, Alonso-Gonzalez R, et al
Catheter ablation for patients with end-stage complex congenital heart disease or cardiomyopathy considered for transplantation: Trials and tribulations.
Int J Cardiol. 2020;301:127-134.
PubMed Abstract available

January 2020

SPEE RF, Niemeijer VM, Schoots T, Tuinenburg A, et al
High intensity interval training after cardiac resynchronization therapy: An explorative randomized controlled trial.
Int J Cardiol. 2020;299:169-174.
PubMed Abstract available

December 2019

GRAMEGNA M, Beneduce A, Bertoldi LF, Pagnesi M, et al
Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization.
Int J Cardiol. 2019 Dec 13. pii: S0167-5273(19)35516.
PubMed Abstract available

October 2019

GARCIA R, Boveda S, Defaye P, Sadoul N, et al
Early mortality after implantable cardioverter defibrillator: Incidence and associated factors.
Int J Cardiol. 2019 Oct 30. pii: S0167-5273(19)33062.
PubMed Abstract available

June 2019

BACKHAUS SJ, Kowallick JT, Stiermaier T, Lange T, et al
Atrioventricular mechanical coupling and major adverse cardiac events in female patients following acute ST elevation myocardial infarction.
Int J Cardiol. 2019 Jun 16. pii: S0167-5273(19)30773.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.